Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Marita Mariotti"'
Autor:
Michela Palleschi, Andrea Prochowski Iamurri, Emanuela Scarpi, Marita Mariotti, Roberta Maltoni, Francesca Mannozzi, Domenico Barone, Giovanni Paganelli, Michela Casi, Emanuela Giampalma, Ugo De Giorgi, Andrea Rocca
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Body composition parameters (BCp) have been associated with outcome in different tumor types. However, their prognostic value in patients with HER2-positive metastatic breast cancer (BC) receiving first line treatment with dual anti-HER2 ant
Externí odkaz:
https://doaj.org/article/491eb08b4bc644f5bf11ddfefef2efc2
Autor:
Filippo Merloni, Michela Palleschi, Caterina Gianni, Chiara Casadei, Annalisa Curcio, Antonino Romeo, Maddalena Rocchi, Simona Cima, Marianna Sirico, Samanta Sarti, Lorenzo Cecconetto, Marita Mariotti, Giandomenico Di Menna, Ugo De Giorgi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Approximately 6% of metastatic breast cancers arise de novo. While systemic therapy (ST) remains the treatment backbone as for patients with metachronous metastases, locoregional treatment (LRT) of the primary tumor remains a controversial method. Th
Externí odkaz:
https://doaj.org/article/5b7a5769ddd3442daaf032bdb9c3abff
Autor:
Matteo Canale, Elisabetta Petracci, Paola Cravero, Marita Mariotti, Gabriele Minuti, Giulio Metro, Vienna Ludovini, Sara Baglivo, Maurizio Puccetti, Alessandra Dubini, Giovanni Martinelli, Angelo Delmonte, Lucio Crinò, Paola Ulivi
Publikováno v:
Translational Oncology, Vol 23, Iss , Pp 101471- (2022)
Non-small-cell lung cancer (NSCLC) is the primary cause of cancer-related death. Gene rearrangements involving the anaplastic lymphoma kinase (ALK) tyrosine kinase identify a clinical and molecular subset of NSCLC patients, who benefit from the monot
Externí odkaz:
https://doaj.org/article/9fcffe32bbf24565b0725968e3ffe4ea
Autor:
Caterina Gianni, Michela Palleschi, Filippo Merloni, Giandomenico Di Menna, Marianna Sirico, Samanta Sarti, Alessandra Virga, Paola Ulivi, Lorenzo Cecconetto, Marita Mariotti, Ugo De Giorgi
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 14197 (2022)
Identifying novel circulating biomarkers predictive of response and informative about the mechanisms of resistance, is the new challenge for breast cancer (BC) management. The integration of omics information will gradually revolutionize the clinical
Externí odkaz:
https://doaj.org/article/711ecaf84a754b818ec2b7a815fe817b
Autor:
Rossana Berardi, Candida Mastroianni, Giuseppe Lo Russo, Roberta Buosi, Daniele Santini, Agnese Montanino, Carlo Carnaghi, Marcello Tiseo, Rita Chiari, Andrea Camerini, Sandro Barni, Valeria De Marino, Daris Ferrari, Antonella Cristofano, Laura Doni, Federica Freddari, Daniele Fumagalli, Luigi Portalone, Roberta Sarmiento, Giovanni Schinzari, Francesca Sperandi, Marcello Tucci, Alessandro Inno, Libero Ciuffreda, Marita Mariotti, Cinzia Mariani, Miriam Caramanti, Mariangela Torniai, Rosaria Gallucci, Chiara Bennati, Paola Bordi, Lucio Buffoni, Achille Galeassi, Michele Ghidini, Emidio Grossi, Alessandro Morabito, Bruno Vincenzi, Emanuela Arvat
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Hyponatremia in cancer patients is often caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The aim of this observational multicenter study was to analyze the medical and economic implications of SIADH in this
Externí odkaz:
https://doaj.org/article/35962965fe4b448a9213dbbff50072dc
Autor:
Paola Ulivi, Angelo Delmonte, Elisa Chiadini, Daniele Calistri, Maximilian Papi, Marita Mariotti, Alberto Verlicchi, Angela Ragazzini, Laura Capelli, Alessandro Gamboni, Maurizio Puccetti, Alessandra Dubini, Marco Angelo Burgio, Claudia Casanova, Lucio Crinò, Dino Amadori, Claudio Dazzi
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 1, Pp 747-757 (2014)
Tyrosine kinase inhibitors (TKIs) are very efficacious in non-small-cell lung cancer (NSCLC) patients harboring activating Epidermal Growth Factor Receptor (EGFR) mutations. However, about 10% of EGFR wild type (wt) patients respond to TKI, with unkn
Externí odkaz:
https://doaj.org/article/aa48d14f07ab4dc495ac417bc830c095
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Purpose: To analyze the impact of TP53 mutations on response to first-line tyrosine kinase inhibitors (TKI) in patients with EGFR-mutated non–small cell lung cancer (NSCLC).Experimental Design: 136 EGFR-mutated NSCLC patients receiving first-line T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23d47bb549e33379e5931ad94663ae8
https://doi.org/10.1158/1078-0432.c.6525968
https://doi.org/10.1158/1078-0432.c.6525968
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Relation of TP53 mutations and clinical characteristics of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039484f724f298b67c10c5e59cad9947
https://doi.org/10.1158/1078-0432.22465238
https://doi.org/10.1158/1078-0432.22465238
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Distribution of disruptive and non-disruptive mutations in the different types of TP53 mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e44015238e6e527258bbb5c74f3225
https://doi.org/10.1158/1078-0432.22465241.v1
https://doi.org/10.1158/1078-0432.22465241.v1
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Association between TP53 and EGFR mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327c5e4f2f415859ce8e3780347f776c
https://doi.org/10.1158/1078-0432.22465235
https://doi.org/10.1158/1078-0432.22465235